Qmiiz ODT™ (meloxicam) – New drug approval
October 19, 2018 - The FDA announced the approval of TerSera Therapeutics’ Qmiiz ODT (meloxicam), for the relief of the signs and symptoms of osteoarthritis (OA) in adults; rheumatoid arthritis (RA) in adults; and pauciarticular and polyarticular course juvenile rheumatoid arthritis (JRA) in pediatric patients who weigh greater than or equal to 60 kg.
Top